Frankincense — Boswellia (Boswellia serrata): The Sacred Anti-Inflammatory
Frankincense — the resinous extract of Boswellia serrata and related species — has been burned in religious ceremonies and used medicinally across the ancient world for over five thousand years. In Ayurvedic medicine, where it is known as Shallaki, Boswellia resin has been used for inflammatory joint conditions, respiratory disease, and gut inflammation. In the modern evidence base, it has emerged as one of the most clinically well-validated herbal anti-inflammatories available — with a mechanism of action distinct from NSAIDs and a safety profile that makes it suitable for long-term use.
At Herba Naturalle, Frankincense Boswellia is listed in the comprehensive herb index as a primary systemic anti-inflammatory — working at the level of the smooth muscle lining and immune system that Anjela Jeganathan’s clinical philosophy places at the root of chronic disease.
Active Compounds
- Boswellic acids — the primary anti-inflammatory compounds; particularly AKBA (3-O-acetyl-11-keto-beta-boswellic acid), the most potent
- Mechanism: AKBA specifically inhibits 5-lipoxygenase (5-LOX) — an enzyme that produces leukotrienes; importantly, Boswellia does NOT inhibit COX enzymes (unlike NSAIDs), meaning it does not cause the gastric bleeding associated with NSAID use
- Incensole acetate — neuroprotective and anti-inflammatory compound relevant to brain health applications
Clinical Evidence and Applications
Osteoarthritis and Rheumatoid Arthritis
Multiple RCTs confirm significant reductions in joint pain, swelling, and stiffness with Boswellia extract. A head-to-head trial found comparable efficacy to valdecoxib (a COX-2 inhibitor) for knee osteoarthritis — with the Boswellia group showing sustained benefit even after the treatment period ended, suggesting disease-modifying rather than merely symptom-suppressing effects. The Smooth Muscle and Immune Reset Bundle provides complementary smooth muscle anti-inflammatory support.
Inflammatory Bowel Disease
Clinical trials in both Crohn’s disease and ulcerative colitis show Boswellia extract producing remission rates comparable to the pharmaceutical mesalazine. The 5-LOX inhibiting mechanism specifically reduces the leukotriene-mediated inflammation of the intestinal mucosa. The Digestive Reset Bundle and Marshmallow Root Plus provide complementary gut lining support.
Asthma
5-LOX inhibition directly reduces the leukotriene-driven bronchoconstriction and airway inflammation of asthma. A clinical trial found significant improvements in FEV1 and reduction in asthma attacks with Boswellia extract. The Lungwort Plus provides complementary respiratory support.
Brain Tumours and Cerebral Oedema
Boswellia reduces the cerebral oedema associated with brain tumours — documented in clinical trials; a specialist application requiring oncological supervision.
How to Use
- Standardised extract (AKBA ≥30%): 300–400mg three times daily — the most evidence-backed form
- Tincture (1:3): 3–5ml three times daily
- Allow 4–8 weeks for full anti-inflammatory benefit
Safety
Outstanding safety profile:
- GI discomfort: Occasional mild nausea — take with food
- Pregnancy: Avoid — insufficient safety data
- Anticoagulants: Mild theoretical interaction
Contact Herba Naturalle for anti-inflammatory herbal support. Browse all products and the full herb index.
This article is for informational purposes only. Please consult a qualified medical herbalist before use.